Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8089)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 15, 2020 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang L, Dong XZ, Xing XX, Cui XH, Li L, Zhang L. Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis. World J Gastrointest Oncol 2020; 12(11): 1346-1363 [PMID: 33250966 DOI: 10.4251/wjgo.v12.i11.1346] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i11/1346.htm |
| Number | Citing Articles |
| 1 |
Ping Qiu, Xing Li, Min Gong, Ping Wen, Jianbo Wen, Linfang Xu, Guiliang Wang, Alessandro Granito. SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway. Canadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/2021515
|
| 2 |
SuA Oh, Eunyoung Kim, Heeyoung Lee. Comparative Impact of PD-1 and PD-L1 Inhibitors on Advanced Esophageal or Gastric/Gastroesophageal Junction Cancer Treatment: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(16): 3612 doi: 10.3390/jcm10163612
|
| 3 |
Jian-Xin Cui, Xian-Hui Xu, Tao He, Jia-Jia Liu, Tian-Yu Xie, Wen Tian, Jun-Yan Liu. L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02629-w
|
| 4 |
Ying Huang, Zhenhua Yang, Lei Zhang. Polyphenol Supplementation Enhances the Efficacy of PD-1/PD-L1 Inhibitors Against Cancer: A Meta-Analysis of Animal Studies. Nutrition and Cancer 2024; 76(1): 17 doi: 10.1080/01635581.2023.2277477
|
| 5 |
Maryam Noori, Farideh Jafari-Raddani, Zeinab Davoodi-Moghaddam, Mahda Delshad, Saeid Safiri, Davood Bashash. Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-023-03183-3
|
| 6 |
Jingyi Hou, Ruiyang Xie, Zhuo Zhang, Qianxin Liu, Qian Xiang, Yimin Cui. Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1163971
|
| 7 |
Aung Naing, Kyriakos P Papadopoulos, Michael J Pishvaian, Osama Rahma, Glenn J Hanna, Elena Garralda, Omar Saavedra, Sven Gogov, Howard Kallender, LuLu Cheng, Michael Smith, Xuejun Chen, Emil Kuriakose, Todd Bauer. First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours. BMJ Oncology 2024; 3(1): e000249 doi: 10.1136/bmjonc-2023-000249
|
| 8 |
伊莎 张. Meta Analysis of the Efficacy and Safety of PD-1/PD-L1 Inhibitors in Patients with Advanced Esophageal Cancer after Surgery, Radiotherapy, or Chemotherapy. Advances in Clinical Medicine 2024; 14(01): 1888 doi: 10.12677/ACM.2024.141267
|
| 9 |
Lili Zhai, Wenjing Chen, Boshu Cui, Bing Yu, Yang Wang, Huiming Liu. Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer. Tissue and Cell 2021; 73: 101611 doi: 10.1016/j.tice.2021.101611
|
| 10 |
Salmaan Kanji, Sydney Morin, Kyla Agtarap, Debanjali Purkayastha, Pierre Thabet, Dominick Bosse, Xiang Wang, Carole Lunny, Brian Hutton. Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews. Drugs 2022; 82(7): 793 doi: 10.1007/s40265-022-01707-1
|
| 11 |
Burcin Pehlivanoglu, S. Mehtat Unlu. Biomarkers in Carcinoma of Unknown Primary. 2022; : 165 doi: 10.1007/978-3-030-84432-5_7
|
| 12 |
Xudong Dai, Yong Chen, Ning Chen, Jin Dou, Haiwen Zhuang, Jian Wang, Xin Zhao, Xiaoyu Zhang, Haijian Zhao. KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer. Immunopharmacology and Immunotoxicology 2023; 45(2): 140 doi: 10.1080/08923973.2022.2122498
|
| 13 |
Tian Zhang, Yi Wang, Chunhui Shi, Xiaochun Liu, Shangbin Lv, Xin Wang, Weihong Li. Pancreatic injury following immune checkpoint inhibitors: A systematic review and meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.955701
|
| 14 |
Taned Chitapanarux, Pawut Gumrai, Sarawut Kongkarnka, Komson Wannasai, Nirush Lertprasertsuke. Programmed death-ligand 1 expression and overall survival in Thai patients with gastric cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34434-y
|
| 15 |
Shuwei Guo, Chao Huang, Fengfeng Han, Bin Chen, Ying Ding, Yuanyuan Zhao, Zhihong Chen, Shaodi Wen, Mei Wang, Bo Shen, Wei Zhu, Xiao Kang Li. Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth. Stem Cells International 2021; 2021: 1 doi: 10.1155/2021/9989790
|